M. K. Çakar Et Al. , "The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma," Journal of Oncology Pharmacy Practice , vol.26, no.2, pp.273-278, 2020
Çakar, M. K. Et Al. 2020. The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma. Journal of Oncology Pharmacy Practice , vol.26, no.2 , 273-278.
Çakar, M. K., Tekgündüz, E., Dal, M. S., Merdin, A., Başçı, S., Uğur, B., ... Bekdemir, F.(2020). The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma. Journal of Oncology Pharmacy Practice , vol.26, no.2, 273-278.
Çakar, Merih Et Al. "The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma," Journal of Oncology Pharmacy Practice , vol.26, no.2, 273-278, 2020
Çakar, Merih K. Et Al. "The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma." Journal of Oncology Pharmacy Practice , vol.26, no.2, pp.273-278, 2020
Çakar, M. K. Et Al. (2020) . "The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma." Journal of Oncology Pharmacy Practice , vol.26, no.2, pp.273-278.
@article{article, author={Merih K Çakar Et Al. }, title={The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma}, journal={Journal of Oncology Pharmacy Practice}, year=2020, pages={273-278} }